Colin Smith Mackay

Symbiosis Pharmaceutical Services Ltd. is a pharmaceutical contract development and manufacturing organization established in 2011 in Scotland. The British company specializes in providing niche sterile manufacturing services to GMP standards and producing injectable products for its clients to use in their clinical trials or to supply specialist commercial markets. Symbiosis Pharma has a manufacturing facility that can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients who are developing medicines to treat cancers and neurodegenerative diseases. The CEO of the private company is Colin Smith Mackay.

Symbiosis Holdings (Scotland) Ltd. is an investment holding British company founded in 2020. The private company is based in Stirling, UK.